MMP9 and congestive heart failure: This observation may reflect that, within the 1-year post-revascularisation period and with patients generally receiving optimal medical therapy, the average LVEF in the high MMP9 group (median 45%) had not yet declined to a point that would consistently trigger the significant compensatory LV dilatation characteristic of more advanced or congestive heart failure.